Your browser doesn't support javascript.
Neutralizing antibodies against SARS-CoV-2 virus after vaccination in patients with neurofibromatosis type 1.
Ruan, Qiao-Ling; Wang, Zhi-Chao; Wei, Cheng-Jiang; Wang, Wei; Yang, Qing-Luan; Wu, Jing; Wan, Yan-Min; Ge, Ling-Ling; Zhang, Wen-Hong; Li, Qing-Feng.
  • Ruan QL; Department of Infectious Diseases, National Medical Center for Infectious Diseases, Shanghai Key Laboratory of Infectious Diseases and Biosafety Emergency Response, Huashan Hospital, Fudan University, Shanghai, People's Republic of China.
  • Wang ZC; Department of Plastic and Reconstructive Surgery, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, People's Republic of China.
  • Wei CJ; Department of Plastic and Reconstructive Surgery, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, People's Republic of China.
  • Wang W; Department of Plastic and Reconstructive Surgery, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, People's Republic of China.
  • Yang QL; Department of Infectious Diseases, National Medical Center for Infectious Diseases, Shanghai Key Laboratory of Infectious Diseases and Biosafety Emergency Response, Huashan Hospital, Fudan University, Shanghai, People's Republic of China.
  • Wu J; Department of Infectious Diseases, National Medical Center for Infectious Diseases, Shanghai Key Laboratory of Infectious Diseases and Biosafety Emergency Response, Huashan Hospital, Fudan University, Shanghai, People's Republic of China.
  • Wan YM; Department of Infectious Diseases, National Medical Center for Infectious Diseases, Shanghai Key Laboratory of Infectious Diseases and Biosafety Emergency Response, Huashan Hospital, Fudan University, Shanghai, People's Republic of China.
  • Ge LL; Department of Plastic and Reconstructive Surgery, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, People's Republic of China.
  • Zhang WH; Department of Infectious Diseases, National Medical Center for Infectious Diseases, Shanghai Key Laboratory of Infectious Diseases and Biosafety Emergency Response, Huashan Hospital, Fudan University, Shanghai, People's Republic of China. zhangwenhong@fudan.edu.cn.
  • Li QF; Shanghai Huashen Institute of Microbes and Infections, Shanghai, People's Republic of China. zhangwenhong@fudan.edu.cn.
Signal Transduct Target Ther ; 8(1): 233, 2023 06 02.
Article in English | MEDLINE | ID: covidwho-20242181
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Neurofibromatosis 1 / COVID-19 Topics: Vaccines Limits: Humans Language: English Journal: Signal Transduct Target Ther Year: 2023 Document Type: Article

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Neurofibromatosis 1 / COVID-19 Topics: Vaccines Limits: Humans Language: English Journal: Signal Transduct Target Ther Year: 2023 Document Type: Article